Gå direkt till huvudinnehållet


Senast uppdaterad: Publicerad:

  1. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505. PubMed  
  2. Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician 2007; 75: 373-6. PubMed  
  3. Parvovirus B19 (erythema infectiosum, fifth disease). In: Red Book 2006: Report of the Committee on Infectious Diseases. 27th ed. Washington, D.C.: American Academy of Pediatrics, 2006: 484-7.
  4. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-97. New England Journal of Medicine  
  5. Brown KE, Mori J, Cohen BJ, Field AM. In vitro propagation of parvovirus B19 in primary foetal liver culture. J Gen Virol 1991; 72: 741-5. PubMed  
  6. Srivastava CH, Zhou S, Munshi NC, Srivastava A. Parvovirus B19 replication in human umbilical cord blood cells. Virology 1992; 189: 456-61. PubMed  
  7. Plummer FA, Hammond GW, Forward K, Sekla L, Thompson LM, Jones SE, et al. An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med 1985; 313: 74-9. New England Journal of Medicine  
  8. Nesher G, Moore TL. Human parvovirus infection. Infect Med 1997; 14: 638-42. PubMed  
  9. Naides SJ, Scharosch LL, Foto F, Howard EJ. Rheumatologic manifestations of human parvovirus B19 infection in adults. Arthritis Rheum 1990; 33: 1297-309. PubMed  
  10. Smith-Whitley K, Zhao H, Hodinka RL, Kwiatkowski J, Cecil R, Cecil T, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood 2004; 103: 422-7. Blood  
  11. Posfay-Barbe KM, Michaels MG. Parvovirus B19 in organ transplant recipients. Curr Opin Organ Transpl 2003; 8: 283-7. PubMed  
  12. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321: 519-23. New England Journal of Medicine  
  13. Alfadley A, Aljubran A, Hainau B, Alhokail A. Papular-purpuric "gloves and socks" syndrome in a mother and daughter. J Am Acad Dermatol 2003; 48: 941-4. PubMed  
  14. Metry D, Katta R. New and emerging pediatric infections. Dermatol Clin 2003; 21: 269-76. PubMed  
  15. Katta R. Parvovirus B19: a review. Dermatol Clin 2002; 20: 333-42. PubMed  
  16. Edmonson MB, Riedesel EL, Williams GP, Demuri GP. Generalized petechial rashes in children during a parvovirus B19 outbreak. Pediatrics 2010; 125: 787-92. Pediatrics  
  17. Alger LS. Toxoplasmosis and parvovirus B19. Infect Dis Clin North Am 1997; 11: 55-75. PubMed  
  18. Morey AL, Keeling JW, Porter HJ, Fleming KA. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 1992; 99: 566-74. PubMed  
  19. American College of Obstetrics and Gynecologists. ACOG practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000. Int J Gynaecol Obstet 2002; 76: 95-107. PubMed  
  20. Institute for Clinical Systems Improvement. Prenatal care, routine. Accessed June 9, 2006, at: http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=191.
  21. Doyle S, Kerr S, O'Keeffe G, O'Carroll D, Daly P, Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods 2000; 90: 143-52. PubMed  
  22. Ballou WR, Reed JL, Noble W, Young NS, Koenig S. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis 2003; 187: 675-8. PubMed  
  • Bertil Christensson, professor och överläkare, Infektionskliniken, Skånes universitetssjukhus

Tidigare sakkunniga

  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim